Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Other
BRIEF-Immunocore Qtrly Loss Per Share $0.47
Feb 26 (Reuters) - Immunocore Holdings PLC IMCR.O:IMMUNOCORE - QTRLY LOSS PER SHARE $0.47 IMMUNOCORE - QTRLY NET SALES $84.1 MILLION
Reuters
Wed, Feb 26
Cryptocurrencies
With Bitcoin (BTC) Struggling at $96K, Investors Anticipate a 2400% Surge in This Emerging Crypto
As Bitcoin struggles to break past $96,000, investors are turning to high-growth opportunities like Mutuum Finance (MUTM). This emerging DeFi project is gaining attention for its decentralized lending model and passive income potential. Currently priced at $0.015 in its presale, MUTM offers an early entry point before its expected surge. Analysts predict a 2400% increase […]
Cryptopolitan
Wed, Feb 26
Other
US abstains from WTO condemnation of Russia's aggression in Ukraine, sources say
By Olivia Le PoidevinGENEVA, Feb 26 (Reuters) - The United States on Wednesday abstained from co-sponsoring a joint statement at the World Trade Organization condemning Russia's aggression in Ukraine, a diplomatic source and a Geneva trade official told Reuters.It is the first time the U.S. has ...
Reuters
Wed, Feb 26
Other
BRIEF-Innoviz Technologies Q4 EPS USD -0.11 Versus. Ibes Estimate USD -0.14
Feb 26 (Reuters) - Innoviz Technologies Ltd INVZ.O:INNOVIZ TECHNOLOGIES Q4 EPS USD -0.11 VERSUS. IBES ESTIMATE USD -0.14INNOVIZ TECHNOLOGIES Q4 OPERATING INCOME USD -19.249 MILLION VERSUS. IBES ESTIMATE USD -25.1 MILLIONINNOVIZ TECHNOLOGIES Q4 NET INCOME USD -18.596 MILLION VERSUS. IBES ESTIMATE USD...
Reuters
Wed, Feb 26
Other
BRIEF-Horizon Quantum Computing Pte And DMY Squared Technology Group Sign Non-Binding Letter Of Intent
Feb 26 (Reuters) - DMY Squared Technology Group Inc DMYY.A:HORIZON QUANTUM COMPUTING PTE. LTD. AND DMY SQUARED TECHNOLOGY GROUP, INC. SIGN NON-BINDING LETTER OF INTENT FOR A BUSINESS COMBINATIONDMY SQUARED TECHNOLOGY GROUP INC - PRE-MONEY EQUITY VALUE OF HORIZON QUANTUM APPROXIMATELY $500 MILLIONDMY...
Reuters
Wed, Feb 26
Other
Germany's Social Democrats riled by Merz ahead of critical talks on coalition
SPD agrees to start talks with Merz's conservatives, demands effective negotiationsMerz faces formidable challenge after surge in voter support for far right and far leftSPD stress support not automatic as investors cite urgency of viable government to tackle debt brake, upgrade to military Publ...
Reuters
Wed, Feb 26
Other
BRIEF-Bkv Corp Q4 Adjusted EPS $0.01
Feb 26 (Reuters) - BKV Corp BKV.N:BKV CORP - Q4 ADJUSTED EPS $0.01BKV CORP - Q4 TOTAL REVENUES AND OTHER OPERATING INCOME $119.8 MILLIONSource text: ID:nBw7y2VR7aFurther company coverage: BKV.N
Reuters
Wed, Feb 26
Other
BRIEF-Option Care Health Inc QTRLY Net Revenue Of $1,346.4 Million
Feb 26 (Reuters) - Option Care Health Inc OPCH.O:: QTRLY NET REVENUE OF $1,346.4 MILLIONEXPECTS 2025 NET REVENUE OF $5.3 BILLION TO $5.5 BILLION: OUTLOOK FY ADJUSTED EPS OF $1.59 TO $1.69: QTRLY ADJUSTED EPS $0.44FY2025 EARNINGS PER SHARE VIEW $1.25, REVENUE VIEW $5.26 BILLION -- LSEG IBES DATAQ4 EA...
Reuters
Wed, Feb 26
Other
BRIEF-Ring Energy Announces Accretive Bolt-On Acquisition
Feb 26 (Reuters) - Ring Energy Inc REI.A:RING ENERGY ANNOUNCES ACCRETIVE BOLT-ON ACQUISITIONRING ENERGY INC - PURCHASE PRICE INCLUDES $80 MILLION CASH, $10 MILLION DEFERRED PAYMENT, 7.4 MILLION SHARESSource text: ID:nGNX6ycZjnFurther company coverage: REI.A
Reuters
Wed, Feb 26
Other
BRIEF-3M Provides Medium-Term Financial Outlook At 2025 Investor Day
Feb 26 (Reuters) - 3M Co MMM.N:3M PROVIDES MEDIUM-TERM FINANCIAL OUTLOOK AT 2025 INVESTOR DAY; PRESENTS STRATEGIC PRIORITIES THAT WILL DRIVE GROWTH, OPERATIONAL EXCELLENCE, AND RETURN CASH TO SHAREHOLDERS3M CO - TO RETURN AT LEAST $10 BILLION IN CASH TO SHAREHOLDERS3M CO - REITERATES 2025 GUIDANCE, ...
Reuters
Wed, Feb 26
Other
BRIEF-United Parks & Resorts Inc QTRLY Revenue Was $384.4 Million
Feb 26 (Reuters) - United Parks & Resorts Inc PRKS.N:QTRLY REVENUE WAS $384.4 MILLIONQTRLY EPS $0.50Q4 EARNINGS PER SHARE VIEW $0.63, REVENUE VIEW $381.3 MILLION -- LSEG IBES DATASource text: ID:nPn5qfr51aFurther company coverage: PRKS.N
Reuters
Wed, Feb 26
Other
BRIEF-Valens Semiconductor Q4 Revenue USD 16.665 Million
Feb 26 (Reuters) - Valens Semiconductor Ltd VLN.N:VALENS SEMICONDUCTOR Q4 REVENUE USD 16.665 MILLIONVALENS SEMICONDUCTOR Q4 ADJUSTED GROSS MARGIN 64.5%VALENS SEMICONDUCTOR Q4 OPERATING EXPENSES USD -18.483 MILLIONVALENS SEMICONDUCTOR Q4 ADJUSTED EBITDA USD -3.688 MILLIONVALENS SEMICONDUCTOR Q4 ADJUS...
Reuters
Wed, Feb 26
Other
BRIEF-Perfect Corp Anticipates A Year-Over-Year Total Revenue Growth Rate Of 13% To 14.5% For 2025, Compared To 2024
Feb 26 (Reuters) - Perfect Corp SZ9.F:PERFECT CORP: ANTICIPATES A YEAR-OVER-YEAR TOTAL REVENUE GROWTH RATE OF 13% TO 14.5% FOR 2025, COMPARED TO 2024PERFECT CORP QTRLY EPS $0.01Source text: ID:nBw9TbMC1aFurther company coverage: SZ9.F
Reuters
Wed, Feb 26
Other
BRIEF-Madrigal Announces Two-Year Data From The Compensated Mash Cirrhosis Arm Of The Maestro-Nafld-1 Trial
Feb 26 (Reuters) - Madrigal Pharmaceuticals Inc MDGL.O:MADRIGAL ANNOUNCES NEW TWO-YEAR DATA FROM THE COMPENSATED MASH CIRRHOSIS ARM OF THE MAESTRO-NAFLD-1 TRIAL DEMONSTRATING POTENTIAL BENEFIT OF REZDIFFRA™ (RESMETIROM) IN PATIENTS WITH COMPENSATED MASH CIRRHOSISMADRIGAL PHARMACEUTICALS INC - REPORT...
Reuters
Wed, Feb 26
Other
BRIEF-Kestra Medical Technologies IPO Price Expected Between $14.00 And $16.00 Per Share
Feb 26 (Reuters) - Kestra Medical Technologies Inc KMTS.O:KESTRA MEDICAL TECHNOLOGIES LTD - IPO PRICE EXPECTED BETWEEN $14.00 AND $16.00 PER SHAREKESTRA MEDICAL TECHNOLOGIES LTD - SEES IPO OF UP TO 10 MILLION COMMON SHARESFurther company coverage: KMTS.O
Reuters
Wed, Feb 26
Other
BRIEF-Revelation Biosciences Doses First Patient In Prime Phase 1B Clinical Study Of Gemini In CKD Patients
Feb 26 (Reuters) - Revelation Biosciences Inc REVB.O:REVELATION BIOSCIENCES DOSES FIRST PATIENT IN PRIME PHASE 1B CLINICAL STUDY OF GEMINI IN CKD PATIENTSREVELATION BIOSCIENCES INC - TOP-LINE DATA EXPECTED BY MID-YEARSource text: ID:nBw4fk9lgaFurther company coverage: REVB.O
Reuters
Wed, Feb 26
Other
BRIEF-Dole Q4 Revenue USD 2,167 Million
Feb 26 (Reuters) - Dole PLC DOLE.N:DOLE Q4 REVENUE USD 2,167 MILLIONDOLE Q4 ADJUSTED EBITDA USD 74.6 MILLIONDOLE Q4 EPS CONTINUING OPERATIONS USD 0.23DOLE Q4 ADJUSTED EPS USD 0.16DOLE Q4 ADJUSTED NET INCOME USD 15.3 MILLIONDOLE PLC - FOR OWN OPERATIONS, WILL FACE KNOWN SHORT-TERM HEADWIND IN 2025 FO...
Reuters
Wed, Feb 26
Other
BRIEF-Escalade Q4 EPS USD 0.19
Feb 26 (Reuters) - Escalade Inc ESCA.O:ESCALADE Q4 EPS USD 0.19ESCALADE Q4 BASIC EPS USD 0.2ESCALADE Q4 SALES USD 63.942 MILLIONESCALADE Q4 OPERATING INCOME USD 4.513 MILLIONESCALADE Q4 NET INCOME USD 2.7 MILLIONESCALADE Q4 PRETAX PROFIT USD 4.267 MILLIONESCALADE INC SAYS BOARD AUTHORIZED CURRENT SH...
Reuters
Wed, Feb 26
Other
BRIEF-Lowe's Outlook FY EPS USD 12.15-12.4
Feb 26 (Reuters) - Lowe's Companies Inc LOW.N:LOWE'S OUTLOOK FY EPS USD 12.15-12.4LOWE'S Q4 EPS USD 1.99LOWE'S Q4 SALES USD 18,553 MILLION VERSUS. IBES ESTIMATE USD 18,292 MILLIONLOWE'S Q4 NET INCOME USD 1,125 MILLION VERSUS. IBES ESTIMATE USD 1,041 MILLIONLOWE'S Q4 OPERATING...
Reuters
Wed, Feb 26
Other
BRIEF-Avista Corp Initiated Consolidated Guidance Of $2.52 To $2.72 Per Share For 2025
Feb 26 (Reuters) - Avista Corp AVA.N:INITIATED CONSOLIDATED GUIDANCE OF $2.52 TO $2.72 PER SHARE FOR 2025EARNINGS PER DILUTED SHARE FOR Q4 2024 WAS $0.84: OVER THE LONG TERM, EXPECTS EARNINGS GROWTH IN THE 4-6 PERCENT RANGE FROM OUR FORECAST 2025 BASE YEARQ4 EARNINGS PER SHARE VIEW $0.86 -- LSEG IBE...
Reuters
Wed, Feb 26
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free